ArticleFrontiers in endocrinology2025
Association of triglyceride glucose body mass index with osteoporosis risks in a large Chinese adult cohort.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Insulin resistance (IR) is implicated in bone metabolism dysregulation, but the role of Triglyceride Glucose Body Mass Index (TyG-BMI), a surrogate marker integrating lipid-glucose metabolism and adiposity, in osteoporosis risk remains underexplored. Methods: We analyzed 23,930 participants categorized into TyG-BMI quartiles (Q1-Q4). Baseline characteristics, biochemical profiles, and medication use were compared. Osteoporosis incidence was tracked over a 4-year median follow-up. Cox models estimated hazard ratios (HRs) for osteoporosis across quartiles of TyG-BMI, adjusted for confounders. Stratified analyses were performed to explore the effect modification by age, sex, renal function, smoking, and medication use. Results: Osteoporosis incidence (1,134 cases) rose sharply from Q1 (71 cases) to Q4 (855 cases).Participants in Q4 (highest TyG-BMI) were younger (mean age 56.2 Conclusion: Elevated TyG-BMI independently predicts incident osteoporosis, with the highest risk in younger males, smokers, and individuals with preserved renal function. TyG-BMI may serve as a practical tool for early osteoporosis risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.